---
document_datetime: 2026-01-09 15:30:18
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/onureg-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: onureg-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.5900328
conversion_datetime: 2026-01-10 11:32:19.493222
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.1
  docling: 2.67.0
  docling-core: 2.58.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Onureg

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| PSUSA/10935 /202405  | Periodic Safety Update EU Single assessment - azacitidine (oral formulations)                                                                        | 16/01/2025                          | n/a                                         |                                  | PRAC Recommendation - maintenance |
| IB/0004/G            | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP | 22/08/2023                          | n/a                                         |                                  |                                   |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | control/testing takes place B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place   |            |            |                 |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------|
| IA/0005             | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                    | 21/08/2023 | n/a        |                 |                                   |
| PSUSA/10935 /202205 | Periodic Safety Update EU Single assessment - azacitidine (oral formulations)                                                                                                                                                                                                                                                                   | 01/12/2022 | n/a        |                 | PRAC Recommendation - maintenance |
| IAIN/0002           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                          | 23/07/2021 | 22/07/2022 | Annex II and PL |                                   |